News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Kevin E. Lofton Joins Gilead Sciences, Inc.'s Board of Directors
July 30, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Kevin E. Lofton has been appointed to the company’s Board of Directors, bringing the number of Directors to 12.
Twitter
LinkedIn
Facebook
Email
Print
People
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Layoff Tracker
Pfizer, Geron Downsize To Streamline Costs
December 12, 2025
·
95 min read
·
BioSpace Editorial Staff
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
December 11, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report
December 11, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend
December 10, 2025
·
1 min read
·
Annalee Armstrong
